Yahoo Finance1mon
Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar
moderate to severe plaque psoriasis and active psoriatic arthritis indications of its originator biologic Stelara ®** Fresenius Kabi logo (CNW Group/Fresenius Kabi Canada Inc.) "This is Fresenius ...
Joplin Globe11d
Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System
Fresenius Kabi Receives FDA 510 (k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora ...
Contract Pharma10d
FDA Grants 510(k) Clearance for Fresenius Kabi’s Adaptive Nomogram
The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...